Literature DB >> 32269047

Case of using mycophenolate in combination with steroids for concurrent macrophage activation syndrome and lupus flare.

Kavina Shah1, Andrew Porter2, Gagandeep Takhar2, Venkat Reddy3.   

Abstract

This report highlights the importance of tailored treatment strategies in severe systemic lupus erythematosus (SLE) flares driving the life-threatening condition, macrophage activation syndrome (MAS). We report the case of a 42-year-old woman with active systemic lupus erythematosus (SLE) who was diagnosed with MAS within 3 days of onset of lethargy, rash, joint pain and significant cytopenias. This early diagnosis meant that her condition was managed with less intensive immunosuppression with only modest doses of steroids and mycophenolate mofetil. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  connective tissue disease; haematology (incl blood transfusion); rheumatology; systemic lupus erythematosus

Mesh:

Substances:

Year:  2020        PMID: 32269047      PMCID: PMC7167458          DOI: 10.1136/bcr-2019-231554

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Macrophage activation syndrome as an early presentation of Lupus.

Authors:  Liza J McCann; Nathan Hasson; Clarissa A Pilkington
Journal:  J Rheumatol       Date:  2006-02       Impact factor: 4.666

Review 2.  Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature.

Authors:  Hafize Emine Sönmez; Selcan Demir; Yelda Bilginer; Seza Özen
Journal:  Clin Rheumatol       Date:  2018-04-16       Impact factor: 2.980

3.  Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.

Authors:  Edward M Behrens; Timothy Beukelman; Michele Paessler; Randy Q Cron
Journal:  J Rheumatol       Date:  2007-03-01       Impact factor: 4.666

Review 4.  Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults.

Authors:  Shunichi Kumakura; Yohko Murakawa
Journal:  Arthritis Rheumatol       Date:  2014-08       Impact factor: 10.995

Review 5.  Macrophage cytokines: involvement in immunity and infectious diseases.

Authors:  Guillermo Arango Duque; Albert Descoteaux
Journal:  Front Immunol       Date:  2014-10-07       Impact factor: 7.561

6.  Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil.

Authors:  Takashi Nawata; Makoto Kubo; Kosaku Shiragami; Yukinori Nakamura; Masafumi Yano
Journal:  Case Rep Rheumatol       Date:  2017-09-14

7.  Clinical features of macrophage activation syndrome as the onset manifestation of juvenile systemic lupus erythematosus.

Authors:  Satoshi Sato; Yoji Uejima; Yuki Arakawa; Mihoko Furuichi; Eisuke Suganuma; Shuichiro Fujinaga; Atsuko Nakazawa; Yutaka Kawano
Journal:  Rheumatol Adv Pract       Date:  2019-05-14

8.  Haemophagocytic lymphohisticytosis-an underrecognized hyperinflammatory syndrome.

Authors:  Matthew Hutchinson; Rachel S Tattersall; Jessica J Manson
Journal:  Rheumatology (Oxford)       Date:  2019-11-01       Impact factor: 7.580

9.  Macrophage Activation Syndrome (MAS) in a Recently Released Prisoner with Systemic Lupus Erythematosus (SLE).

Authors:  Robert Szulawski; Peter J Kourlas; Marc Antonchak
Journal:  Am J Case Rep       Date:  2018-06-22

10.  Macrophage Activation Syndrome, Glomerulonephritis, Pericarditis, and Retinal Vasculitis as Initial Presentation of Systemic Lupus Erythematosus.

Authors:  Yiming Luo; Yumeng Wen; Ana Belen Arevalo Molina; Punya Dahal; Lorenz Leuprecht; Makda Bsrat
Journal:  Case Rep Med       Date:  2018-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.